Blair Gage
@blairkgage.bsky.social
Scientist Ottawa Hospital Research Institute and Asst. Prof. at uOttawa Dept of CMM | #CellTherapist fighting #LiverDisease, #VascularDisease and #Hemophilia with #StemCells and #LSECs | he/him
https://www.ohri.ca/profile/bgage
https://www.ohri.ca/profile/bgage
Pinned
Blair Gage
@blairkgage.bsky.social
· Nov 24
I'm happy to join the blusky community. We're studying hPSC derived liver endothelium to build #CellTherapy for Hemophilia and liver disease while we discovery what makes liver ECs tick. I'm actively recruiting graduate students to join us in Ottawa.
Reposted by Blair Gage
Our job posting for 1 or more PDF positions in Vancouver Canada is now live here: tinyurl.com/4mrjw3m2
Please share/repost and apply soon!
Please share/repost and apply soon!
February 25, 2025 at 11:02 PM
Our job posting for 1 or more PDF positions in Vancouver Canada is now live here: tinyurl.com/4mrjw3m2
Please share/repost and apply soon!
Please share/repost and apply soon!
Reposted by Blair Gage
Although it's only January, slots are filling up quickly for #GRC_Angiogenesis! If you love blood vessels and wanna dig into their interactions with their neighbors, Newport is the place to be this summer! We will soon start selecting abstracts for short talks! Don't wait, apply today. Link 👇
January 24, 2025 at 12:13 PM
Although it's only January, slots are filling up quickly for #GRC_Angiogenesis! If you love blood vessels and wanna dig into their interactions with their neighbors, Newport is the place to be this summer! We will soon start selecting abstracts for short talks! Don't wait, apply today. Link 👇
New year, New lab members! Welcome Hakam, Khyldoon, and Annie to the lab.
January 13, 2025 at 2:03 PM
New year, New lab members! Welcome Hakam, Khyldoon, and Annie to the lab.
www.nejm.org/doi/full/10....
Lentivirus FVIII for Hemophilia A, looks promising! Could this be a multi decade durable therapy?
Lentivirus FVIII for Hemophilia A, looks promising! Could this be a multi decade durable therapy?
Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A | NEJM
Severe hemophilia A is managed with factor VIII replacement or hemostatic products
that stop or prevent bleeding. Data on gene therapy with hematopoietic stem-cell (HSC)–based
expression of factor ...
www.nejm.org
December 10, 2024 at 1:04 AM
www.nejm.org/doi/full/10....
Lentivirus FVIII for Hemophilia A, looks promising! Could this be a multi decade durable therapy?
Lentivirus FVIII for Hemophilia A, looks promising! Could this be a multi decade durable therapy?
Congrats to the Protze lab at the McEwen Stem Cell Institute in Toronto on their first publication as a lab!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Single-cell transcriptome analysis reveals CD34 as a marker of human sinoatrial node pacemaker cardiomyocytes - Nature Communications
Lim et al. identify CD34 as a surface marker of the heart’s sinoatrial node pacemaker cells, enabling their isolation from stem cell differentiation cultures, advancing future disease modeling, drug d...
www.nature.com
November 29, 2024 at 12:57 AM
Congrats to the Protze lab at the McEwen Stem Cell Institute in Toronto on their first publication as a lab!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
I'm happy to join the blusky community. We're studying hPSC derived liver endothelium to build #CellTherapy for Hemophilia and liver disease while we discovery what makes liver ECs tick. I'm actively recruiting graduate students to join us in Ottawa.
November 24, 2024 at 3:15 PM
I'm happy to join the blusky community. We're studying hPSC derived liver endothelium to build #CellTherapy for Hemophilia and liver disease while we discovery what makes liver ECs tick. I'm actively recruiting graduate students to join us in Ottawa.